ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Endocrinology therapeutic area by Year
Endocrinology therapeutic area — Worldwide revenue ($M) [legacy grouping through FY2019] ($M)
Eli Lilly Endocrinology therapeutic area: $10,085M in FY2017, up 24.8% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2018-02-20) ↗
Reported in Form 10-K Note 2 (legacy Endocrinology grouping).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Endocrinology therapeutic area — Worldwide revenue ($M) [legacy grouping through FY2019] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 10,085 | +24.8% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 8,083 | +14.9% | Form 10-K (filed 2018-02-20) ↗ |
| FY2015 | Dec 31, 2015 | 7,037 | +1.4% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 6,939 | -5.0% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 7,304 | +7.2% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 6,811 | +0.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2011 | Dec 31, 2011 | 6,807 | – | Form 10-K (filed 2014-02-19) ↗ |
Breakdown
What makes up endocrinology therapeutic area
Cite this data
StockData. (2026). Eli Lilly Endocrinology therapeutic area ($M), annual FY2011–FY2017 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-endocrinology-ww-legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.